Ubs Group Ag Hoth Therapeutics, Inc. Transaction History

Ubs Group Ag

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$0.36 - $9.25 $665 - $17,103	-1,849 Reduced 31.39%	4,042 $1,000
Q2 2022 Aug 10, 2022	SELL	$0.38 - $1.05 $1,735 - $4,795	-4,567 Reduced 43.67%	5,891 $2,000
Q1 2022 May 16, 2022	BUY	$0.52 - $1.3 $5,438 - $13,595	10,458 New	10,458 $7,000
Q4 2021 Feb 14, 2022	SELL	$0.66 - $1.18 $641 - $1,146	-972 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$1.15 - $1.62 $1,117 - $1,574	972 New	972 $1,000
Q2 2021 Aug 13, 2021	SELL	$1.31 - $2.14 $7,071 - $11,551	-5,398 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$1.85 - $3.04 $1,383 - $2,273	748 Added 16.09%	5,398 $11,000
Q4 2020 Feb 11, 2021	BUY	$1.58 - $2.37 $7,347 - $11,020	4,650 New	4,650 $11,000
Q3 2020 Nov 12, 2020	SELL	$1.86 - $3.15 $1,129 - $1,912	-607 Closed	0 $0
Q2 2020 Jul 31, 2020	BUY	$2.53 - $4.08 $230 - $371	91 Added 17.64%	607 $2,000
Q1 2020 May 01, 2020	SELL	$2.62 - $6.59 $4,011 - $10,089	-1,531 Reduced 74.79%	516 $2,000
Q4 2019 Feb 14, 2020	BUY	$3.34 - $6.19 $5,818 - $10,782	1,742 Added 571.15%	2,047 $13,000
Q3 2019 Nov 14, 2019	SELL	$4.25 - $7.18 $8,415 - $14,216	-1,980 Reduced 86.65%	305 $1,000
Q2 2019 Aug 14, 2019	BUY	$4.76 - $8.1 $9,891 - $16,831	2,078 Added 1003.86%	2,285 $13,000
Q1 2019 May 14, 2019	BUY	$5.15 - $8.53 $1,066 - $1,765	207 New	207 $1,000

Ticker HOTH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,288,470
Market Cap $1.08M
Description
Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor ...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.